Tengion Inc. To Present Organ-Regeneration Medicine

Armen Hareyan's picture
Advertisement

Tengion Inc., a clinical stage regenerative medicine company focused on the development of neo-organs and neo-vessels, announced today that Steven Nichtberger, M.D., President and Chief Executive Officer, will be presenting at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on Tuesday, February 5, 2008 at 9:20 a.m. EST. The conference will be held at the Grand Hyatt Hotel in New York City.

Tengion's Autologous Organ Regeneration Platform, with a focus on the development of the company's first investigational product, the Tengion Neo-Bladder

Advertisement